<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Drug Discovery Market Reports]]></title>
    <link>http://www.reportlinker.com/report/search/isAdwords//isCountryAdwords//theme/drug_discovery</link>
    <description><![CDATA[Reportlinker.com Lastest Drug Discovery Market Reports]]></description>
    <pubDate>Mon, 20 May 2013 22:05:45 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Drug Discovery Market Statistics]]></title>
      <link>http://www.reportlinker.com/d013683597/Drug-Discovery-Market-Statistics.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013683597/Drug-Discovery-Market-Statistics.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... To be correct at the time of publication, no responsibility can be accepted by s ltd for its completeness or accuracy.         Iii table of contents  emerging <strong>drug</strong> <strong>discovery</strong> technologies ...]]></description>
      <pubDate>Fri, 31 Dec 2010 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery Industry Statistics]]></title>
      <link>http://www.reportlinker.com/d012638463/Drug-Discovery-Industry-Statistics.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012638463/Drug-Discovery-Industry-Statistics.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Timelines  <Strong>drug</strong> companies look for a commercial  market and a fair chance of success slide no 4     R&d   expenditure versus annual  nme approvals, 1995-2005     From: winning r&d productivity ...]]></description>
      <pubDate>Sat, 30 Apr 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Market]]></title>
      <link>http://www.reportlinker.com/d012285649/Drug-Discovery-and-Development-Market.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012285649/Drug-Discovery-and-Development-Market.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Solutions to accelerate inn   Strong track record after >1hamburg years <strong>drug</strong> <strong>discovery</strong> histor   >100 Lead series   > 30 Preclinical cand   > 20 Clinical compounds   Comprehensive integrated ...]]></description>
      <pubDate>Mon, 31 Jan 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Sector]]></title>
      <link>http://www.reportlinker.com/d012286509/Drug-Discovery-and-Development-Sector.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012286509/Drug-Discovery-and-Development-Sector.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Effects   Facilitate for more patients  possible to treat, longer treatment duration, better disease control  potential indications: inflammatory diseases such as ra, asthma and psoriasis   <strong>drug</strong> <strong>discovery</strong> ...]]></description>
      <pubDate>Thu, 31 Mar 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Industry]]></title>
      <link>http://www.reportlinker.com/d011950699/Drug-Discovery-and-Development-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d011950699/Drug-Discovery-and-Development-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... <Strong>discovery</strong> s   and  development  as y for  solutions to  our partnersovery  solutions to <strong>drug</strong>  one stop shop from target screening hit-to-lead lead optimisation target id &  validation   Assay  development ...]]></description>
      <pubDate>Mon, 31 Jan 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Sector]]></title>
      <link>http://www.reportlinker.com/d012396056/Drug-Discovery-and-Development-Sector.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012396056/Drug-Discovery-and-Development-Sector.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... In-class technologies to accelerate   Stop-loss  Or investment s in <strong>discovery</strong>  (e.G. Hts,  In vivo models ,  ) Rug <strong>discovery</strong> alliances & product development  artnerships build even stronger portfolio of long ...]]></description>
      <pubDate>Fri, 31 Dec 2010 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Sector]]></title>
      <link>http://www.reportlinker.com/d012282019/Drug-Discovery-and-Development-Sector.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012282019/Drug-Discovery-and-Development-Sector.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... In-class technologies to accelerate   Stop-loss  Or investment s in <strong>discovery</strong>  (e.G. Hts,  In vivo models ,  ) Rug <strong>discovery</strong> alliances & product development  artnerships build even stronger portfolio of long ...]]></description>
      <pubDate>Mon, 31 Jan 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery and Development Business]]></title>
      <link>http://www.reportlinker.com/d014229939/Drug-Discovery-and-Development-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014229939/Drug-Discovery-and-Development-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... If a <strong>drug</strong>, adsorption, distribution, metabolism and excretion   Toxicity    Endpoints   Inclusion/exclusion criteria   Details of evaluation (when, where and what)   Sample size determination, including ...]]></description>
      <pubDate>Thu, 31 Mar 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Discovery : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d012947111/Drug-Discovery-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012947111/Drug-Discovery-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... For therapeutic efficacy. Natural products still play a major role as starting materials for <strong>drug</strong> <strong>discovery</strong>.  According to a report  published in 2007 that covers <strong>drug</strong> development between 1981 and 2006, of 974 ...]]></description>
      <pubDate>Tue, 31 Jan 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Australian Drug Discovery and Development Industry]]></title>
      <link>http://www.reportlinker.com/d012873083/The-Australian-Drug-Discovery-and-Development-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012873083/The-Australian-Drug-Discovery-and-Development-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Screening platform using phylomers as probes to identify and  val <strong>drug</strong> targets  in-house target <strong>discovery</strong> focusing on high-value disease pathways phylogica and cambridge/mrc setting up new uk ...]]></description>
      <pubDate>Tue, 31 Jan 2012 23:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
